Barclays PLC Intellipharmaceutics International Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$0.21 - $2.55 $372 - $4,526
-1,775 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$2.4 - $5.3 $4,260 - $9,407
1,775 New
1,775 $5,000

About Intellipharmaceutics International Inc.

IPCIF Quotes by TradingView
  • Ticker IPCIF
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,092,700
  • Market Cap $4.96M
  • Description
  • Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in...
More about IPCIF
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email